FDA.reportPublic FDA data

BCNU 7.7 MG Drug Implant

RxCUI
309013
RxNorm name
BCNU 7.7 MG Drug Implant
Display name
BCNU 7.7 MG Drug Implant
Full name
BCNU 7.7 MG Drug Implant
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:54

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
GliadelCARMUSTINEAzurity Pharmaceuticals, Inc.38962a55-a514-4c48-bea5-f99a8da4beec2024-12-05Warnings, Adverse reactionsExact identifier
rxcui: 309013

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
38962a55-a514-4c48-bea5-f99a8da4beeccarmustine 7.7 MG Intracavitary Drug Implant [PSN] · carmustine 7.7 MG Drug Implant [SCD] · BCNU 7.7 MG Drug Implant [SY] · carmustine 7.7 MG Wafer [SY]48These highlights do not include all the information needed to use GLIADEL WAFER safely and effectively. See full prescribing information for GLIADEL WAFER. GLIADEL ® WAFER (carmustine implant), for intracranial use Initial U.S. Approval: 199620241205